Status:
TERMINATED
Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment
Lead Sponsor:
Montefiore Medical Center
Conditions:
Acute Pain
Eligibility:
All Genders
18-100 years
Phase:
PHASE4
Brief Summary
In this case series study, the investigators are testing the hypothesis that sublingual sufentanil (Dsuvia) will improve postoperative pain management in the Post Anesthesia Care Unit (PACU) in ambula...
Eligibility Criteria
Inclusion
- Age range 18-100 years
- Currently taking Suboxone
- ASA (American Society of Anesthesiology) physical score 1-3
- Able to provide a signed informed consent
- General anesthesia (either endotracheal intubation or laryngeal mask airway) or MAC (monitored anesthesia care) without the use of regional anesthesia
Exclusion
- Known allergic reactions to Dsuvia and its excipients
- Severe respiratory illness including exacerbation of asthma attack
- Significant intraoperative hemodynamic instability
- Use of Regional anesthesia techniques
Key Trial Info
Start Date :
September 27 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 18 2022
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT04716413
Start Date
September 27 2021
End Date
November 18 2022
Last Update
July 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montefiore Medical Center
The Bronx, New York, United States, 10467